Endra logo

Investor Relations

Corporate Overview

ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS®) system to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI -- at a fraction of the cost, and at the point-of-care.


TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD) (formerly known as NAFLD-NASH), a chronic liver disease spectrum that affects over two billion people globally, and for which there are no practical diagnostic tools.


Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Quick Links

Latest News

Latest Events

Fourth Quarter 2023 Financial Results

Date: March 28, 2024

Time: 4:30 PM ET

Webcast Link

See more. Do more. Live better.™

Share by: